Ana Lisa Basquiera

14PUBLICATIONS
101CO-AUTHORS
NanomedicineRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 06, 2026
Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry.

|Apr 01, 2026
American Society of Hematology 2026 guidelines for the diagnosis and management of severe and very severe acquired aplastic anemia.

Phillip Scheinberg, Debra A O'Neal, Ana Lisa Basquiera

|Jul 07, 2025
Lymphocytic Variant Hypereosinophilic Syndrome With Extensive Mucocutaneous Involvement Successfully Treated With Ruxolitinib.

Ana Romina Montivero, Camila Anderlini, Gabriela Luque

|Jun 26, 2025
Progress in the Genetics of Myelodysplastic Syndromes with a Latin American Perspective.

Ana Lisa Basquiera, Verónica Andreoli, Sofía Grille

|Apr 18, 2025
Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors.

Sebastian Galeano, Carmem Bonfim, Amado Karduss

|Mar 16, 2025
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study.

David J Kuter, Waleed Ghanima, Nichola Cooper

Pageof 3

Frequent Collaborators

2 joint publications

Sebastian Galeano

2 joint publications

Verónica Andreoli

2 joint publications

Dietger Niederwieser

2 joint publications

María José Mela Osorio